Alphatec (ATEC)
(Delayed Data from NSDQ)
$10.87 USD
-0.04 (-0.37%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $10.86 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
ATEC 10.87 -0.04(-0.37%)
Will ATEC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ATEC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ATEC
Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength?
ATEC: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Other News for ATEC
Alphatec Holdings (ATEC): Strong Sales and Improving Cash Burn Profile Justify Buy Rating
ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI
ATEC to Report Second Quarter Financial Results on July 31, 2024
What's Driving Tandem Diabetes Care Inc's Surprising 15% Stock Rally?
PROCEPT BioRobotics Corp's Meteoric Rise: Unpacking the 25% Surge in Just 3 Months